Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

Supply chain resilience is critical in industries with high-risk products and strict regulatory demands, such as healthcare.

DUBLIN--(BUSINESS WIRE)--The "Pharma Supply Chain & Security World 2025" conference has been added to ResearchAndMarkets.com's offering. The Annual Pharma Supply Chain & Security World Summit is ...

From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like Amicus Therapeutics of New Jersey, which is looking for a non-Chinese company to supply raw materials for ...

U.S. drugmakers and biotechs have come to rely on Chinese partners for manufacturing, research and ingredients. Now, some of them are looking for alternatives as geopolitical tensions rise.

The investment will also support efforts to shore up the UK’s supply chain of critical medicines and boost UK health resilience. The Chancellor welcomed the investment, which comes two days ...

NEW YORK, Oct 31 (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits ...

BEIJING - The head of multinational pharmaceutical giant AstraZeneca’s China arm is under investigation in the country, the firm said. Mr Leon Wang, president of AstraZeneca China, is ...

The supply improvement is a testament to the fact that Novo's “intentional approach to gradually increase supply into the U.S. market is working,” the spokesperson added. Notably, while all ...

"We think that OPEC+ could delay the increase in supply until end of March/beginning of April of 2025, given that demand will drop in Q1 2025 from Q4 2024 because of seasonal factors," said John ...

Reports of drug-related supply-chain issues were 40 percent less likely to result in drug shortages in Canada versus the United States, according to a new study.